207 related articles for article (PubMed ID: 20687621)
1. Oral bepotastine: in allergic disorders.
Lyseng-Williamson KA
Drugs; 2010 Aug; 70(12):1579-91. PubMed ID: 20687621
[TBL] [Abstract][Full Text] [Related]
2. Bepotastine besilate for the treatment of pruritus.
Bielory L; Duttachoudhury S; McMunn A
Expert Opin Pharmacother; 2013 Dec; 14(18):2553-69. PubMed ID: 24191914
[TBL] [Abstract][Full Text] [Related]
3. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.
Abelson MB; Torkildsen GL; Williams JI; Gow JA; Gomes PJ; McNamara TR;
Clin Ther; 2009 Sep; 31(9):1908-21. PubMed ID: 19843481
[TBL] [Abstract][Full Text] [Related]
4. Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis.
Williams JI; Kennedy KS; Gow JA; Torkildsen GL; Abelson MB; Gomes PJ; McNamara TR;
J Ocul Pharmacol Ther; 2011 Aug; 27(4):385-93. PubMed ID: 21649522
[TBL] [Abstract][Full Text] [Related]
5. Bepotastine besilate for the treatment of perennial allergic rhinitis.
Carrillo-Martin I; Gonzalez-Estrada A; Dimov V
Expert Opin Pharmacother; 2018 Oct; 19(15):1727-1730. PubMed ID: 30208284
[TBL] [Abstract][Full Text] [Related]
6. Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders.
Wiseman LR; Faulds D
Drugs; 1996 Feb; 51(2):260-77. PubMed ID: 8808167
[TBL] [Abstract][Full Text] [Related]
7. Analysis of disease-dependent sedative profiles of H(1)-antihistamines by large-scale surveillance using the visual analog scale.
Izumi N; Mizuguchi H; Umehara H; Ogino S; Fukui H
Methods Find Exp Clin Pharmacol; 2008 Apr; 30(3):225-30. PubMed ID: 18597008
[TBL] [Abstract][Full Text] [Related]
8. Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults.
Kalis B
Drugs; 1996; 52 Suppl 1():30-4. PubMed ID: 8828024
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride, a new antiallergic drug.
Ohmori K; Hayashi K; Kaise T; Ohshima E; Kobayashi S; Yamazaki T; Mukouyama A
Jpn J Pharmacol; 2002 Apr; 88(4):379-97. PubMed ID: 12046981
[TBL] [Abstract][Full Text] [Related]
10. Double-blind placebo-controlled study of bepotastine besilate in pediatric patients with perennial allergic rhinitis.
Okubo K; Ichimura M; Koyama T; Susuta Y; Izaki H
Expert Opin Pharmacother; 2015; 16(16):2395-408. PubMed ID: 26364765
[TBL] [Abstract][Full Text] [Related]
11. Non-clinical pharmacology, pharmacokinetics, and safety findings for the antihistamine bepotastine besilate.
Williams JI; Gow JA; Klier SM; McCue SL; Salapatek AM; McNamara TR
Curr Med Res Opin; 2010 Oct; 26(10):2329-38. PubMed ID: 20735291
[TBL] [Abstract][Full Text] [Related]
12. Ebastine in allergic rhinitis and chronic idiopathic urticaria.
Sastre J
Allergy; 2008 Dec; 63 Suppl 89():1-20. PubMed ID: 19032340
[TBL] [Abstract][Full Text] [Related]
13. A review of the second-generation antihistamine ebastine for the treatment of allergic disorders.
Van Cauwenberge P; De Belder T; Sys L
Expert Opin Pharmacother; 2004 Aug; 5(8):1807-13. PubMed ID: 15264995
[TBL] [Abstract][Full Text] [Related]
14. Rupatadine for the treatment of allergic rhinitis and urticaria.
Metz M; Maurer M
Expert Rev Clin Immunol; 2011 Jan; 7(1):15-20. PubMed ID: 21162645
[TBL] [Abstract][Full Text] [Related]
15. H1-antihistamines in the elderly.
Kaliner MA
Clin Allergy Immunol; 2002; 17():465-81. PubMed ID: 12113227
[TBL] [Abstract][Full Text] [Related]
16. Effects of bepotastine and fexofenadine on histamine-induced flare, wheal and itch.
Tanizaki H; Ikoma A; Fukuoka M; Miyachi Y; Kabashima K
Int Arch Allergy Immunol; 2012; 158(2):191-5. PubMed ID: 22286689
[TBL] [Abstract][Full Text] [Related]
17. [Antihistaminics. Side effects also after raising dosage at the placebo level].
MMW Fortschr Med; 2003 May; 145(22):50-1. PubMed ID: 12866280
[No Abstract] [Full Text] [Related]
18. Health-related quality of life assessed by the effect of bepotastine besilate in patients with pruritus: importance of emotions score in atopic dermatitis.
Kawakami T; Kimura S; Haga T; Doi R; Kyoya M; Nakagawa K; Soma Y
J Dermatol; 2012 Jun; 39(6):527-30. PubMed ID: 22035542
[TBL] [Abstract][Full Text] [Related]
19. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
Takahashi H; Ishida-Yamamoto A; Iizuka H
Clin Exp Dermatol; 2004 Sep; 29(5):526-32. PubMed ID: 15347340
[TBL] [Abstract][Full Text] [Related]
20. Integrated phase III trials of bepotastine besilate ophthalmic solution 1.5% for ocular itching associated with allergic conjunctivitis.
Meier EJ; Torkildsen GL; Gow JA; McNamara TR; Gomes PJ; Williams JI;
Allergy Asthma Proc; 2012; 33(3):265-74. PubMed ID: 22991696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
